COVID-19: DCGI nod to Serum Institute of India for phase 2 and 3 human clinical trials of Oxford vaccine candidate

Government officials told PTI that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee on -19.

from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/31g34Ol
via IFTTT

Comments

Post a Comment

Popular posts from this blog

11 areas with 70% of cases asked to scale up Covid fight

Image
The Centre on Saturday asked the 11 municipal areas accounting for 70% of active Covid-19 cases to step up testing for early detection, timely clinical management and a reduction in fatality rate. The 11 areas with high case-load are in seven states - Maharashtra, Tamil Nadu, Gujarat, Delhi, Madhya Pradesh, West Bengal and Rajasthan. from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/3ecc4Zn via IFTTT
Read more